Tonia Sylvester: Why She Fights …the medical team noticed a cluster of tiny little brown spots on her lower leg, which is referred to as…
Interview with Allison Betof Warner, MD, PhD: TIL Therapy …types of melanoma? Acral, mucosal, cutaneous, and melanoma of unknown primary origin are approved. These types of melanoma were included…
In Plain English: Options for Stage III Melanoma …III melanoma is considered high-risk—meaning it has a high likelihood of recurring or spreading. In fact, patients with Stage III…
In Plain English—Intratumoral Injection: Boosting the immune response against metastatic melanoma by the direct injection of immunotherapy into tumor masses By Kim Margolin, M.D. Using the patient’s own immune system to combat melanoma is a powerful tool for patients…
A Melanoma Story of Sisters, Love, and Healing …her sister’s life interrupted, in 2010, Alice Googled “melanoma” and the results of the search turned up AIM at Melanoma’s…
USDA Accepts for Priority Review Bristol Myers Squibb’s Application for LAG-3-Blocking Antibody Relatlimab and Nivolumab Fixed-Dose Combination as Treatment for Patients with Unresectable or Metastatic Melanoma …treated metastatic melanoma; Checkmate 066–previously untreated metastatic melanoma; Checkmate 067–previously untreated metastatic melanoma, as a single agent or in combination…
President’s Letter | September 2022 …survivor stories: Please meet Erich Djordjevic and Bev Johnson. Erich is a Stage IV brain mets survivor, and Bev is…
AIM at Melanoma Opens The First Branch of Fresh Frozen Primary Tissue Bank at the University of Pittsburgh Medical Center (UPMC), Hillman Cancer Center …are welcome to query Alicia Rowell, Vice President, AIM at Melanoma Foundation (Alicia@AIMatMelanoma.org). ABOUT THE AIM AT MELANOMA FOUNDATION:…
AIM at Melanoma Earns a Four-Star Rating From Charity Navigator …AIM at Melanoma is dedicated to finding more effective treatments and, ultimately, the cure for melanoma while improving the lives…
Jimmy Carter: A Life that Shaped Cancer Treatment and Hope for Melanoma Patients …(brand name Yervoy), was approved for melanoma in 2011, and other immunotherapy approvals for melanoma followed in 2014 and 2015.…
Jun. 09, 2026 The FDA Just Approved a New Sunscreen Ingredient— What It Means for Patients with Skin Cancer, Survivors, and the General Public
Jun. 05, 2026 Results for darovasertib in combination with crizotinib in first line HLA*A2:01-negative metastatic uveal melanoma met the study’s primary objective
Jun. 05, 2026 Encouraging results with anzutresgene autoleucel in patients with uveal melanoma and other melanoma subtypes
Jun. 05, 2026 Promising early results with imneskibart, low-dose subcutaneous IL-2, and nivolumab in patients who do not respond to or who relapse after receiving combination checkpoint inhibitors